Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

4basebio Plc (4BB) Share Price

Price 560.00p on 05-02-2026 at 13:25:06
Change 0.00p 0%
Buy 600.00p
Sell 520.00p
Last Trade: Buy 173.00 at 573.22p
Day's Volume: 0
Last Close: 560.00p
Open: 560.00p
ISIN: GB00BMCLYF79
Day's Range 560.00p - 560.00p
52wk Range: 560.00p - 1,200.00p
Market Capitalisation: £86.72m
VWAP: 0.00p
Shares in Issue: 15.48m

4basebio Plc (4BB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 173 573.22p Ordinary
14:03:31 - 04-Feb-26
Unknown* 1,650 575.40p Ordinary
08:43:28 - 03-Feb-26
Sell* 70 550.00p Ordinary
08:17:02 - 02-Feb-26
Buy* 89 600.00p Ordinary
08:15:51 - 02-Feb-26
Sell* 811 551.00p Ordinary
12:26:11 - 30-Jan-26
Sell* 11 555.00p Ordinary
09:42:32 - 30-Jan-26
Buy* 1 577.45p Ordinary
08:56:05 - 30-Jan-26
Buy* 50 577.45p Ordinary
15:26:08 - 29-Jan-26
Sell* 41 555.00p Ordinary
08:04:47 - 29-Jan-26
Unknown* 1,500 550.00p Ordinary
16:42:32 - 28-Jan-26
See more 4basebio Plc trades

4basebio Plc (4BB) Share Price History

Time period:
to
Date Open High Low Close Volume
5th Feb 2026 (Thu) 560.00 560.00 560.00 560.00 0
4th Feb 2026 (Wed) 560.00 560.00 560.00 560.00 173
3rd Feb 2026 (Tue) 575.00 575.00 560.00 560.00 2,439
2nd Feb 2026 (Mon) 575.00 575.00 575.00 575.00 159
30th Jan 2026 (Fri) 575.00 575.00 575.00 575.00 961
29th Jan 2026 (Thu) 575.00 575.00 575.00 575.00 91
28th Jan 2026 (Wed) 575.00 575.00 575.00 575.00 2,456
27th Jan 2026 (Tue) 575.00 575.00 575.00 575.00 58
26th Jan 2026 (Mon) 575.00 575.00 575.00 575.00 1,030
23rd Jan 2026 (Fri) 575.00 575.00 575.00 575.00 82
22nd Jan 2026 (Thu) 575.00 575.00 575.00 575.00 84
21st Jan 2026 (Wed) 590.00 590.00 575.00 575.00 1,287
20th Jan 2026 (Tue) 590.00 590.00 590.00 590.00 3,380
19th Jan 2026 (Mon) 590.00 590.00 590.00 590.00 329
16th Jan 2026 (Fri) 590.00 590.00 590.00 590.00 1,753
15th Jan 2026 (Thu) 590.00 590.00 590.00 590.00 298
14th Jan 2026 (Wed) 590.00 590.00 590.00 590.00 500
13th Jan 2026 (Tue) 590.00 590.00 590.00 590.00 0
12th Jan 2026 (Mon) 590.00 590.00 590.00 590.00 193
9th Jan 2026 (Fri) 590.00 590.00 590.00 590.00 2,587
8th Jan 2026 (Thu) 615.00 615.00 590.00 590.00 4,654
7th Jan 2026 (Wed) 615.00 615.00 615.00 615.00 1,665
6th Jan 2026 (Tue) 615.00 615.00 615.00 615.00 1,018
5th Jan 2026 (Mon) 615.00 615.00 615.00 615.00 767
See more 4basebio Plc price history

4basebio Plc (4BB) Regulatory News

Date Source Headline
27th Oct 2025 7:00 am PRN Synthetic opDNA® utilised in Phase I/II US clinical trials
10th Oct 2025 11:30 am PRN Result of Extraordinary General Meeting
30th Sep 2025 4:20 pm PRN Director Dealing
29th Sep 2025 7:00 am PRN Half-year Report
22nd Jul 2025 7:00 am PRN Employee Long Term Incentive Plan and Issue of Equity
8th Jul 2025 10:30 am PRN Director Appointment, Board Change
3rd Jul 2025 7:00 am PRN Holding(s) in Company
3rd Jul 2025 7:00 am PRN Holding(s) in Company
2nd Jul 2025 7:00 am PRN Holding(s) in Company
2nd Jul 2025 7:00 am PRN Holding(s) in Company
See more 4basebio Plc regulatory news

4basebio Plc (4BB) Share News

4basebio says "tier one" partner tests vaccine from its template

27th Oct 2025 12:40

(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More

EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen

1st Oct 2025 12:57

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2025 12:02

Read More

4basebio expects to sustain DNA sales growth momentum in 2025

27th May 2025 11:57

(Alliance News) - 4basebio on Tuesday reported a wider pretax loss in 2024, despite higher revenue, and said it is optimistic about the year to come. Read More

IN BRIEF: 4basebio hits "critical milestone" as it secures GMP licence

2nd Apr 2025 09:51

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Secures good manufacturing practice, or GMP, certification for its UK DNA manufacturing facility from the UK Medicines & Healthcare Products Regulatory Agency. This authorises it to manufacture and supply investigational medicinal product drug substance and critical starting biological medicinal materials used in advanced therapy medicinal products from its Cambridge facility, says the firm. Adds that the certification strengthens its position in the advanced therapeutics field and progresses it towards commercialisation and patient care for a range of advanced therapies. Chief Executive Heikki Lanckriet says: "Achieving GMP certification is a critical milestone for 4basebio, validates our ability to supply synthetic DNA for clinical applications and underscores the hard work and innovation of our team and sets the stage for the next phase of growth for the company." Read More

See more 4basebio Plc news
FTSE 100 Latest
Value10,354.12
Change-48.22

Login to your account

Forgot Password?

Not Registered